Recently, FERMT1’s involvement in tumors, including colorectal cancer [11], stomach cancer [12], breast cancer [11, 13]oral squamous cell carcinoma [14], and nasopharyngeal carcinoma [15], has been documented. The gene discussed is FERMT1; the disease is colorectal cancer.